Go to Home

NEWS

Recent deals, Alliances & news

BIO (Biotechnology Industry Organization) has selected ProPharma for the 5th consecutive year to assist in organizing the 5th annual BIO-Asia Partnering Conference in Tokyo, January, 28-29 2008
Gemin X Biotechnologies and Leo Pharma
Gemin X Biotechnologies licenses world wide rights to GMX1777, a novel pro drug therapeutic for the treatment of refractory solid tumors and Lymphomas from Leo Pharma May 2007
Regen and Metagenics Adobe Acrobat PDF Document
ReGen signs first commercial deal for Colostrinin
Cytogen Corporation and Inpharma AS Adobe Acrobat PDF Document
Cytogen Corporation has licensed the exclusive North American rights to CAPHOSOL® from Inpharma AS.
Asterand and BTG Adobe Acrobat PDF Document
BTG licenses analgesic compounds from Asterand
Sanochemia and Avigen Adobe Acrobat PDF Document
Avigen partners Sanochemia's tolperisone for the North American market.
Cambridge Laboratories and IDM Adobe Acrobat PDF Document
IDM and Cambridge Laboratories sign agreement for Junovan™
Miikana Therapeutics and Roche Adobe Acrobat PDF Document
Miikana licenses Phase II anticancer compound from Roche
BioAsia Partnering ConferenceBIO (Biotechnology Industry Organization) has selected ProPharma to assist in organizing the 3rd annual BioAsia Partnering Conference scheduled for January 31-Feb 1, 2006.
ProPharma Asked Again to Provide Organizational Support to BIO Adobe Acrobat PDF Document
Pfizer and Meridica Adobe Acrobat PDF Document
Pfizer's acquisition of Meridica
Enzon Pharmaceuticals, Inc. and Pharmagene
Cystic fibrosis treatment development collaboration
Sunesis Pharmaceuticals and Dainippon Pharmaceuticals
Cancer product in-license
Replidyne, Inc and Sequoia Sciences Adobe Acrobat PDF Document
Compound/access screening collaboration
Daiichi Pharmaceuticals and Rigel Pharmaceuticals Adobe Acrobat PDF Document
Cancer focused drug discovery partnership
Cerylid Biosciences and Anadys Pharmaceuticals Adobe Acrobat PDF Document
Natural product chemistry collaboration
Metabolex and Yamanouchi Adobe Acrobat PDF Document
Diabetes target discovery partnership
+44 1293 425 300